71.45
price down icon0.75%   -0.54
after-market After Hours: 71.00 -0.45 -0.63%
loading
Soleno Therapeutics Inc stock is traded at $71.45, with a volume of 4.00M. It is down -0.75% in the last 24 hours and up +46.35% over the past month.
See More
Previous Close:
$71.99
Open:
$71.54
24h Volume:
4.00M
Relative Volume:
4.64
Market Cap:
$2.30B
Revenue:
-
Net Income/Loss:
$-38.99M
P/E Ratio:
-23.84
EPS:
-2.9966
Net Cash Flow:
$-24.94M
1W Performance:
+42.50%
1M Performance:
+46.35%
6M Performance:
+41.51%
1Y Performance:
+66.94%
1-Day Range:
Value
$69.87
$73.94
1-Week Range:
Value
$48.29
$73.97
52-Week Range:
Value
$36.61
$73.97

Soleno Therapeutics Inc Stock (SLNO) Company Profile

Name
Name
Soleno Therapeutics Inc
Name
Phone
650-213-8444
Name
Address
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
SLNO's Discussions on Twitter

Compare SLNO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SLNO
Soleno Therapeutics Inc
71.45 2.30B 0 -38.99M -24.94M -2.9966
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-05-25 Resumed Stifel Buy
Dec-02-24 Reiterated Robert W. Baird Outperform
Dec-02-24 Reiterated Stifel Buy
Sep-03-24 Initiated H.C. Wainwright Buy
May-10-24 Initiated Robert W. Baird Outperform
Feb-05-24 Initiated Piper Sandler Overweight
Jan-23-24 Initiated Stifel Buy
Nov-21-23 Resumed Guggenheim Buy
Sep-29-20 Initiated Guggenheim Buy
Jan-10-20 Initiated Craig Hallum Buy
Dec-23-19 Initiated Oppenheimer Outperform
Feb-13-18 Reiterated Maxim Group Buy
View All

Soleno Therapeutics Inc Stock (SLNO) Latest News

pulisher
07:29 AM

Soleno Therapeutics CCO sells shares worth $2.48m - Investing.com

07:29 AM
pulisher
07:29 AM

Soleno therapeutics director Matthew Pauls sells $424,797 in stock - Investing.com

07:29 AM
pulisher
07:27 AM

Soleno Therapeutics CFO sells $4.88 million in stock - Investing.com

07:27 AM
pulisher
07:21 AM

Soleno Therapeutics exec sells shares worth $9.5 million - Investing.com India

07:21 AM
pulisher
07:13 AM

Soleno Therapeutics CEO sells $35.3 million in stock - Investing.com

07:13 AM
pulisher
07:13 AM

Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock - Investing.com

07:13 AM
pulisher
07:10 AM

Soleno Therapeutics Executives Sell Shares - TradingView

07:10 AM
pulisher
08:01 AM

Soleno stock price target raised to $100 at H.C. Wainwright - Investing.com

08:01 AM
pulisher
05:32 AM

Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock By Investing.com - Investing.com South Africa

05:32 AM
pulisher
05:30 AM

Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock - Investing.com India

05:30 AM
pulisher
Mar 30, 2025

Soleno Therapeutics Stock (SLNO) Surges on FDA Green Light for PWS Treatment - Markets Insider

Mar 30, 2025
pulisher
Mar 29, 2025

Why Soleno Therapeutics Inc. (SLNO) Went Up Last Week? - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

10 Stocks Outperform Broader Market Last Week - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

Soleno Therapeutics (NASDAQ:SLNO) Trading 3.9% Higher on Analyst Upgrade - MarketBeat

Mar 29, 2025
pulisher
Mar 29, 2025

SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug - MSN

Mar 29, 2025
pulisher
Mar 29, 2025

Vivo opportunity sells $124 million in Soleno Therapeutics stock By Investing.com - Investing.com South Africa

Mar 29, 2025
pulisher
Mar 29, 2025

Why Soleno Therapeutics Inc. (SLNO) Went Up On Friday? - MSN

Mar 29, 2025
pulisher
Mar 29, 2025

Guggenheim raises Soleno Therapeutics stock target to $81 By Investing.com - Investing.com Canada

Mar 29, 2025
pulisher
Mar 28, 2025

Major Shareholder Sells Massive Stake in Soleno Therapeutics! - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Vivo opportunity sells $124 million in Soleno Therapeutics stock - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Stifel raises Soleno stock target to $108 after FDA approval By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

PANTHERx® Rare Selected by Soleno Therapeutics for the Distribution of VYKAT™ XR - PR Newswire

Mar 28, 2025
pulisher
Mar 28, 2025

Stifel raises Soleno stock target to $108 after FDA approval - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Soleno Therapeutics price target raised to $108 from $74 at Stifel - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

FDA Approves First Therapy To Treat Hyperphagia in Prader-Willi Syndrome - Technology Networks

Mar 28, 2025
pulisher
Mar 28, 2025

Why Soleno Therapeutics Inc. (SLNO) Surged On Thursday? - Insider Monkey

Mar 28, 2025
pulisher
Mar 28, 2025

Soleno Therapeutics Joins Elite Club Of Stocks With RS Ratings Over 90 - Investor's Business Daily

Mar 28, 2025
pulisher
Mar 28, 2025

FDA Greenlights Soleno Therapeutics’ VYKAT XR for PWS Hyperphagia - geneonline.com

Mar 28, 2025
pulisher
Mar 27, 2025

Oppenheimer lifts Soleno Therapeutics stock target to $105 By Investing.com - Investing.com Canada

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease - Mugglehead

Mar 27, 2025
pulisher
Mar 27, 2025

Biotech Zooms Into Breakout Zone On Hard-Fought Approval - Investor's Business Daily

Mar 27, 2025
pulisher
Mar 27, 2025

First Prader-Willi treatment Vykat XR FDA-approved: Soleno soars - BioWorld MedTech

Mar 27, 2025
pulisher
Mar 27, 2025

Drugmaker Soleno Soars on Approval to Treat Never Ending Hunger - Bloomberg.com

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Therapeutics: In No Rush To Join Buying Frenzy Despite Vykat Approval (SLNO) - Seeking Alpha

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno wins FDA approval for Prader-Willi hyperphagia treatment - Yahoo

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Shares Are Up Today: What's Going On? - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

FDA Approves Soleno Therapeutics’ Vykat XR for Hyperphagia in Patients with Prader-Willi Syndrome - Pharmaceutical Executive

Mar 27, 2025
pulisher
Mar 27, 2025

Baird Raises Soleno Therapeutics' Price Target to $102 From $72, Outperform Rating Maintained - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Therapeutics: A Breakthrough in Rare Disease Treatment - RagingBull

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno’s Vykat Gains First Prader-Willi Syndrome Approval, Rivals To Follow - insights.citeline.com

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno stock skyrockets on FDA drug approval - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno breaks through with FDA nod for Prader-Willi syndrome treatment Vykat XR - FiercePharma

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno jumps as analysts say US nod for rare disease drug transforms treatment options - MSN

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Therapeutics execs reap stock windfall after FDA approves rare disease drugSan Francisco Business Times - The Business Journals

Mar 27, 2025
pulisher
Mar 27, 2025

Piper Sandler maintains $93 target on Soleno Therapeutics stock By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Soleno Skyrockets 40% on FDA Nod for VYKAT XR - Wall Street Pit

Mar 27, 2025
pulisher
Mar 27, 2025

Concentrix Posts Better-Than-Expected Earnings, Joins Soleno Therapeutics, Petco Health and Wellness, MillerKnoll And Other Big Stocks Moving Higher On Thursday - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

Stifel maintains Soleno Therapeutics buy rating post FDA nod By Investing.com - Investing.com Australia

Mar 27, 2025
pulisher
Mar 27, 2025

Behind the Scenes of Soleno Therapeutics's Latest Options Trends - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

SLNO stock touches 52-week high at $66.16 amid robust growth - Investing.com India

Mar 27, 2025
pulisher
Mar 27, 2025

Stifel maintains Soleno Therapeutics buy rating post FDA nod - Investing.com India

Mar 27, 2025

Soleno Therapeutics Inc Stock (SLNO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Cap:     |  Volume (24h):